Robo Global Healthcare Technology and Innovation ETF HTEC
44.98 USD -0.77 (-1.67%)
At closeNov 10, 2026, 4:00 PM EST
45.08 +0.10 +0.22%
After hours · Nov 10, 4:00 PM ET
44.65 Day range 45.22
31.85 52-week range 47.25
- YTD
- +27.35%
- 1 year
- +35.03%
News
etftrends.com 3 Reasons HTEC Stands Out Among the Best Health Tech ETFs Every day, headlines extoll the potential in AI investing, and the markets reflect that; the biggest companies in the S&P 500 include the key AI hyperscalers. Still, the impact of AI will be much…
etftrends.com Who's Buying the Future of AI & Robotics: 2026 M&A Report After several years of cooling appetite for M&A and large IPOs, 2026 has seen a resurgence in both, as well as increased appetite for venture fundraising in robotics and physical AI.
etftrends.com How Tempus AI Built a Defensible Data Moat in Precision Healthcare As access to powerful general-purpose AI models expands, access alone offers limited differentiation. In precision healthcare, competitive advantage can come from combining proprietary clinical data,…
etftrends.com How to Invest in AI Drug Discovery .Danaher (DHR), one of the world's largest providers of medical diagnostics and laboratory equipment, recently announced plans to launch its first AI-powered autonomous laboratory, scheduled to…
defenseworld.net ROBO Global Healthcare Technology and Innovation ETF (NYSEARCA:HTEC) Stock Short Interest Report for September ROBO Global Healthcare Technology and Innovation ETF (NYSEARCA:HTEC - Get Free Report) saw a significant increase in short interest in the month of September. As of September 30th, there was short…
etftrends.com How Healthcare Tech ETF HTEC Defied September's Market Turmoil It's always exciting to see a fund perform well over the course of a month, but it's also important to understand exactly why that strong performance may be happening. Key Takeaways: September proved…
etftrends.com The Top HealthTech Questions Landing on Our Desks Strong performance across the healthtech sector over the past two quarters has sparked renewed market interest in medical innovation. Given the volume of inquiries landing on our desks, we compiled…
defenseworld.net ROBO Global Healthcare Technology and Innovation ETF (NYSEARCA:HTEC) Stock Short Interest Falls 81.1% ROBO Global Healthcare Technology and Innovation ETF (NYSEARCA:HTEC - Get Free Report) was the recipient of a large drop in short interest during the month of September. As of September 15th, there…
etftrends.com AI & Robotics in 2026: 16 Recent Developments for Investors If AI and robotics suddenly feel like they are moving faster, August gave investors plenty of evidence that the pace really is accelerating. We saw longer-running agents, faster and cheaper…
etftrends.com Why Moderna's Cancer Vaccine Matters to Investors Healthcare is moving away from the traditional model of mass-produced, one-size-fits-all treatments toward individualized therapies. This evolution in medicine aims to provide treatments that are not…
etftrends.com Cyclosporiasis: Investing in Biosecurity In a year already marked by headlines of Ebola outbreaks and flashback-inducing cruise ship quarantines, everyday foodborne threats are delivering a sharp reminder of supply chain vulnerability.…
etftrends.com Why Pure-Play Healthcare Technology Innovation Matters Portfolios are commonly underexposed to the companies driving healthcare innovation. As technological disruptions build across medical fields, the ROBO Global Healthcare Technology and Innovation ETF…
globenewswire.com HTEC Opens Canada's First 700 Bar Commercial Heavy-Duty Clean Hydrogen Station Station on Tsawwassen First Nation land in British Columbia marks a key milestone for the deployment of hydrogen-powered trucks Station on Tsawwassen First Nation land in British Columbia marks a key…
etftrends.com Industrial ETFs: Riding the Physical AI Supercycle Investors once shrugged off industrials as slow-growth cyclical businesses that lagged tech at every turn. But the AI boom has driven a significant re-rating of the sector.
etftrends.com BBH Survey Highlights Global Shift to Active & Thematic ETFs The 2026 Brown Brothers Harriman (BBH) Global ETF Investor Survey revealed a constant data point — demand for ETFs remains robust on a global scale. However, the current market environment is…
etftrends.com Bull vs. Bear: Are AI ETFs the Best Way to Play the Megatrend? TMX VettaFi writers Ben Hernandez and DJ Shaw delved into the world of crypto ETFs in the last Bull vs. Bear. In this edition, writers Nick Peters-Golden and Elle Fitzgerald focus on artificial…
etftrends.com AI Robotics Investment Opportunities Extend Beyond Big Tech The artificial intelligence and robotics investment opportunity extends far beyond the headline-grabbing tech giants, offering exposure to a diverse ecosystem of enablers and application developers…
benzinga.com Axogen Prices Upsized $124 Million Stock Offering Axogen stock fell Thursday with a session volume of 1.92 million, priced its upsized underwritten public offering at $31.00 per share.
etftrends.com Grail Inc. Early Cancer Detection News Boosts Healthcare Tech ETF HTEC Healthcare technology continues to offer a powerful combination of health care investing durability and tech innovation upside. In an uncertain market, the segment can often prove a reliable source…
benzinga.com Trump's Weight-Loss Drug Push May Put These ETFs On A Diet Trump's vow to slash weight-loss drug prices sent Hims & Hers tumbling. These ETFs are facing new pressure.
etftrends.com Investing in the Future of Healthcare Healthcare has been the worst-performing sector in the S&P 500 this year. But when it comes to unlocking potential capital growth ahead, that may not be all bad news.
etftrends.com ETF Prime: Mercer Explores How AI Is Reshaping Healthcare On this week's episode of ETF Prime, Zeno Mercer, senior research analyst at TMX VettaFi, joins host Nate Geraci to discuss the evolution of healthcare technology.
benzinga.com Federal Judge Halts National Institutes of Health's Grant Policy Overhaul Citing Legal Violations A federal court blocked NIH's policy capping indirect cost rates on research grants, ruling it unlawful. The decision safeguards billions in funding and ongoing clinical trials.
benzinga.com DeepSeek Shakes Up AI Stocks: 3 Healthcare Tech ETFs Offer Stability, Innovation DeepSeek's AI model causes tech stocks to drop, but healthcare tech ETFs benefit from advancements in AI without vulnerability to market volatility.
benzinga.com Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024 According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2023.